CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		86,674,390
Beginning balance at Dec. 31, 2022	$ 178,590	$ 9	$ 194,157	$ (81,697)	$ 12,240	$ 53,881
Beginning balance (in shares) at Dec. 31, 2022				(7,829,661)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(476,718)		(476,718)
Repurchase of common stock	(4,206)			$ (4,206)
Stock-based compensation	1,688		1,688
Exercise of stock-based awards, net of shares withheld (in shares)		247,153
Exercise of stock-based awards, net of shares withheld	(602)		(602)
Unrealized gain (loss) on interest rate caplets, net of taxes	(2,166)				(2,166)
Net income	9,182					9,182
Ending balance (in shares) at Mar. 31, 2023		86,444,825
Ending balance at Mar. 31, 2023	182,486	$ 9	195,243	$ (85,903)	10,074	63,063
Ending balance (in shares) at Mar. 31, 2023				(8,306,379)
Beginning balance (in shares) at Dec. 31, 2023		84,123,385
Beginning balance at Dec. 31, 2023	198,404	$ 8	203,046	$ (112,070)	7,936	99,484
Beginning balance (in shares) at Dec. 31, 2023				(10,893,575)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(594,817)		(594,817)
Repurchase of common stock	(6,182)			$ (6,182)
Stock-based compensation	2,350		2,350
Exercise of stock-based awards, net of shares withheld (in shares)		249,700
Exercise of stock-based awards, net of shares withheld	(940)		(940)
Unrealized gain (loss) on interest rate caplets, net of taxes	1,081				1,081
Net income	7,416					7,416
Ending balance (in shares) at Mar. 31, 2024		83,778,268
Ending balance at Mar. 31, 2024	$ 202,129	$ 8	$ 204,456	$ (118,252)	$ 9,017	$ 106,900
Ending balance (in shares) at Mar. 31, 2024				(11,488,392)